The one‐carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation

Petra Marttila,Nadilly Bonagas,Christina Chalkiadaki,Hannah Stigsdotter,Korbinian Schelzig,Jianyu Shen,Crystal M. Farhat,Amber Hondema,Julian Albers,Elisée Wiita,Azita Rasti,Ulrika Warpman Berglund,Ana Slipicevic,Oliver Mortusewicz,Thomas Helleday
DOI: https://doi.org/10.1002/1878-0261.13645
2024-03-29
Molecular Oncology
Abstract:In this study, we show that the MTHFD2 protein modulates homologous recombination (HR) repair of DNA double‐strand breaks (DSBs) in human cancer cells. After treatment with ionizing radiation, MTHFD2 is recruited, by ATM and DNA‐PK kinases, to the nucleus, where it promotes DNA end resection, and RPA and RAD51 loading during HR repair, thus contributing to cell survival. The one‐carbon metabolism enzyme bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (MTHFD2) is among the most overexpressed proteins across tumors and is widely recognized as a promising anticancer target. While MTHFD2 is mainly described as a mitochondrial protein, a new nuclear function is emerging. Here, we observe that nuclear MTHFD2 protein levels and association with chromatin increase following ionizing radiation (IR) in an ataxia telangiectasia mutated (ATM)‐ and DNA‐dependent protein kinase (DNA‐PK)‐dependent manner. Furthermore, repair of IR‐induced DNA double‐strand breaks (DSBs) is delayed upon MTHFD2 knockdown, suggesting a role for MTHFD2 in DSB repair. In support of this, we observe impaired recruitment of replication protein A (RPA), reduced resection, decreased IR‐induced DNA repair protein RAD51 homolog 1 (RAD51) levels and impaired homologous recombination (HR) activity in MTHFD2‐depleted cells following IR. In conclusion, we identify a key role for MTHFD2 in HR repair and describe an interdependency between MTHFD2 and HR proficiency that could potentially be exploited for cancer therapy.
oncology
What problem does this paper attempt to address?